Harga kembali 1 minggu-1.63%
Harga kembali 1 Bulan2.49%
Harga kembali 3 Bulan-0.38%
Harga kembali 6 Bulan-14.57%
Harga Tertinggi (52 Minggu)157.3
Harga Terendah (52 Minggu)108.54
Latar Belakang Perusahaan
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Summary
Valuation Information
Current PE Ratio (TTM)-50.22
Forward PE Ratio15.22
Current Price to Book Value14.06
Current Price to Sales5.43
EV to Revenue6.18
EV to EBITDA104.4
PEG Ratio-0.91
Per Share
Current EPS (Annualized)-2.65
Diluted EPS (TTM)-2.65
Revenue Per Share24.51
Current Book Value Per Share9.46
Dividend
Dividend Per Share3.22
Dividend Yield0.0246
Ex Dividend Date2026-09-15
Dividend Payment Date2026-06-29
Income Statement
EBITDA14601000000
Profit Margin-0.106
Operating Margin0.337
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
